IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,957,656 | -28.0% | 3,287,397 | +11.4% | 3.99% | -4.5% |
| Q2 2023 | $20,768,831 | +30.0% | 2,950,118 | +12.8% | 4.18% | +0.7% |
| Q1 2023 | $15,977,509 | +16.3% | 2,614,977 | +21.7% | 4.15% | +16.5% |
| Q4 2022 | $13,735,625 | -15.7% | 2,149,550 | +26.4% | 3.56% | -7.6% |
| Q3 2022 | $16,286,000 | +22.9% | 1,700,000 | +41.7% | 3.86% | +4.8% |
| Q2 2022 | $13,248,000 | – | 1,200,000 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |